scispace - formally typeset
A

Anselm K. Gitt

Researcher at Heidelberg University

Publications -  265
Citations -  13930

Anselm K. Gitt is an academic researcher from Heidelberg University. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 51, co-authored 261 publications receiving 12897 citations. Previous affiliations of Anselm K. Gitt include European Society of Cardiology & University of Cyprus.

Papers
More filters
Journal ArticleDOI

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

TL;DR: The If Inhibitor Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Dysfunction is evaluated as well as patients with Diabetes mellitus for Optimal management of Multivessel disease.
Journal ArticleDOI

A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)

TL;DR: This survey demonstrates the discordance between existing guidelines for ACS and current practice across a broad region in Europe and the Mediterranean basin and more extensively reflects the outcomes of ACS in real practice in this region.
Journal ArticleDOI

Gender differences in the management and clinical outcome of stable angina.

TL;DR: Significant gender bias has been identified in the use of investigations and evidence-based medical therapy in stable angina and the observed bias is of particular concern in light of the adverse prognosis observed among women with stableAngina and confirmed coronary disease.
Journal ArticleDOI

Exercise Anaerobic Threshold and Ventilatory Efficiency Identify Heart Failure Patients for High Risk of Early Death

TL;DR: The anaerobic threshold (Vo2AT) and the ventilatory efficiency (Ve versus Vco2 slope) are compared with peak Vo2 in identifying patients with CHF at increased risk for death within 6 months after evaluation.